March 24, 2022
💔 Noticias desalentadoras: un nuevo estudio demuestra que el COVID-19 aumenta el riesgo de enfermedad cardiovascular durante al menos un año después de la infección.
Data and Metrics Long COVID Posts en Español
Aparna Kumar, PhD CRNP MPH
DATOS Y MÉTRICAS SOBRE EL COVID DE LARGA DURACIĂ“N Un estudio reciente aplicado a veteranos de EE. UU. encontrĂł que el riesgo de sufrir un ataque cardĂaco, un derrame cerebral y una larga lista de otros eventos cardiovasculares era más alto para aquellos individuos que se contagiaron con COVID-19 al compararlos durante el año anterior Read more…
March 24, 2022
Moderna will submit for approval of its kids’ vaccine
Families/Kids Vaccines
Jennifer Beam Dowd, PhD
TL;DR: Moderna’s kids vaccine hit high marks for safety and antibody response, but efficacy against mild illness was not as high as earlier trials (likely due to Omicron). Moderna announced yesterday (via press release) that they will submit for Emergency Use Authorization (EUA) of their vaccine for kids aged 6 months to < 6 years. Read more…
DATOS Y MÉTRICAS SOBRE EL COVID DE LARGA DURACIĂ“N Un estudio reciente aplicado a veteranos de EE. UU. encontrĂł que el riesgo de sufrir un ataque cardĂaco, un derrame cerebral y una larga lista de otros eventos cardiovasculares era más alto para aquellos individuos que se contagiaron con COVID-19 al compararlos durante el año anterior Read more…
March 24, 2022
Moderna will submit for approval of its kids’ vaccine
Families/Kids Vaccines
Jennifer Beam Dowd, PhD
TL;DR: Moderna’s kids vaccine hit high marks for safety and antibody response, but efficacy against mild illness was not as high as earlier trials (likely due to Omicron). Moderna announced yesterday (via press release) that they will submit for Emergency Use Authorization (EUA) of their vaccine for kids aged 6 months to < 6 years. Read more…
TL;DR: Moderna’s kids vaccine hit high marks for safety and antibody response, but efficacy against mild illness was not as high as earlier trials (likely due to Omicron). Moderna announced yesterday (via press release) that they will submit for Emergency Use Authorization (EUA) of their vaccine for kids aged 6 months to < 6 years. Read more…

